Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain
Condition(s):Moderate-to-severe Chronic Low Back PainLast Updated:March 5, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Moderate-to-severe Chronic Low Back PainLast Updated:March 5, 2018Completed
Condition(s):Moderate-to-severe Chronic Noncancer PainLast Updated:March 5, 2018Completed
Condition(s):PainLast Updated:March 17, 2017Completed
Condition(s):Allergic RhinitisLast Updated:March 6, 2018Completed
Condition(s):Healthy SubjectsLast Updated:March 15, 2017Completed
Condition(s):Assess Pharmacokinetics of Ketorolac Tromethamine Intranasal and Assess Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac TromethamineLast Updated:February 9, 2017Completed
Condition(s):Postoperative PainLast Updated:March 16, 2017Completed
Condition(s):Healthy VolunteersLast Updated:March 6, 2018Completed
Condition(s):Healthy VolunteersLast Updated:March 16, 2017Completed
Condition(s):Pain; Dental ImpactionLast Updated:February 9, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.